N@N

EMR, FRX, CME, DGX, WAG, BR Expected to Trade Up Short Term

March 21, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top equities trading strategies and these stocks are the most likely to trade Up in the coming weeks. EMERSON ELECTRIC CO (NYSE:EMR), FOREST LABORATORIES INC (NYSE:FRX), CME GROUP INC (NASDAQ:CME), QUEST DIAGNOSTICS INC (NYSE:DGX), WALGREEN CO (NYSE:WAG), BROADRIDGE FINANCIAL SOLUTIO (NYSE:BR) are all expected to go Up as Bullish signals have been generated by top equity trading strategies. This trading system is designed to identify high probability reversion to mean trading candidates. It looks to go long immediately following strong sell-offs, and goes short after sharp run ups. Its trades are short term and hone in on the irrational decisions of emotional traders around these extreme moves. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php The chart below displays the stocks expected to go Up and a suggested stop level to limit any potential trading losses.

     Symbol     Company                             Price          Price Stop Level
     EMR        EMERSON ELECTRIC CO                 57.140         53.12     
     FRX        FOREST LABORATORIES INC             33.000         28.88     
     CME        CME GROUP INC                       285.790        273.59    
     DGX        QUEST DIAGNOSTICS INC               53.740         51.59     
     WAG        WALGREEN CO                         40.910         37.94     
     BR         BROADRIDGE FINANCIAL SOLUTIO        21.120         20.52     

EMERSON ELECTRIC CO (NYSE:EMR) - Emerson Electric Co., a diversified global technology company, engages in designing and supplying product technology, as well as delivering engineering services and solutions to various industrial, commercial, and consumer markets worldwide. Its Process Management segment offers customers product technology, as well as engineering and project management services for precision control, monitoring, and asset optimization of oil and gas reservoirs, and plants that produce power, or that process or treat items, such as oil, natural gas, and petrochemicals; food and beverages; pulp and paper; pharmaceuticals; and municipal water supplies. The companys Industrial Automation segment provides integrated manufacturing solutions to the manufacturers of products, including motors, power transmissions, alternators, fluid controls, and materials joining equipment. Emerson Electrics Network Power segment designs, manufactures, installs, and maintains products providing grid to chip electric power conditioning, power reliability, and environmental control for telecommunication networks, data centers, and other critical applications. This segment offers power systems, embedded power supplies, precision cooling products, inbound power systems, and connectivity products. The companys Climate Technologies segment provides products and services for areas of the climate control industries, including residential, commercial, and industrial heating and air-conditioning, as well as commercial and industrial refrigeration. Its technology enables homeowners and businesses to manage their heating, air-conditioning, and refrigeration systems. In addition, this segment digitally controls and remotely monitors refrigeration units in grocery stores and other food distribution outlets. Emerson Electrics Appliance and Tools segment offers products and solutions in motors, appliances and components, tools and storage areas. The company was founded in 1890 and is based in St. Louis, Missouri.

FOREST LABORATORIES INC (NYSE:FRX) - Forest Laboratories, Inc. develops, manufactures, and sells branded and generic forms of ethical drug products. Its principal products include Lexapro for the treatment of depression in adults and adolescents, and generalized anxiety disorder in adults; Namenda for the treatment of Alzheimer's disease; Bystolic for the treatment of hypertension; and Savella for the management of fibromyalgia. The company is also developing various products, including Daxas, which is in Phase III clinical trial for the treatment of chronic obstructive pulmonary disease (COPD); Ceftaroline that has completed Phase II clinical trial for the treatment of community acquired bacterial pneumonia; ceftazidime/NXL104 combination, which is in Phase II clinical trial; and Linaclotide that is in the Phase III clinical trial for the treatment of constipation-predominant irritable bowel syndrome and chronic constipation. In addition, it is developing Aclidinium, which is in the Phase III clinical trial as an inhaled therapy for COPD; LAS100977 that is in Phase II clinical trial for the treatment of asthma and COPD; Cariprazine, which is in Phase III clinical trial for the treatment of schizophrenia, bipolar mania, and other psychiatric conditions; F2695 that is in pre-clinical stage for the treatment of depression; Radiprodil, which is in Phase II clinical trial for the treatment of chronic pain and other central nervous system conditions; and mGLuR1/5 Compounds for the treatment of anxiety, depression, and other CNS conditions. Forest Laboratories, Inc. sells its products through independent distributors to physicians, pharmacies, hospitals, and managed care and other healthcare organizations. The company was founded in 1956 and is based in New York, New York.

CME GROUP INC (NASDAQ:CME) - CME Group Inc. operates the CME, CBOT, NYMEX, and COMEX regulatory exchanges worldwide. The company provides a range of products available across various asset classes, including futures and options on interest rates, equity indexes, energy, agricultural commodities, metals, foreign exchange, weather, and real estate. It offers various products that provide a means of hedging, speculation, and asset allocation relating to the risks associated with interest rate sensitive instruments, equity ownership, changes in the value of foreign currency, credit risk, and changes in the prices of commodities. CME Group owns and operates clearing house, CME Clearing, which provides clearing and settlement services for exchange-traded contracts and counter derivatives transactions; and also engages in real estate operations. Its primary trade execution facilities consist of its CME Globex electronic trading platform and open outcry trading floors, as well as privately negotiated transactions that are cleared and settled through its clearing house. In addition, the company offers market data services comprising live quotes, delayed quotes, market reports, and historical data services, as well as involves in index services business. CME Groups customer base includes professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, and governments. It has strategic partnerships with BM&FBOVESPA S.A., Bursa Malaysia Derivatives, Singapore Exchange Limited, Green Exchange, Dubai Mercantile Exchange, Johannesburg Stock Exchange, and Bolsa Mexicana de Valores, S.A.B. de C.V., as well as joint venture agreement with Dow Jones & Company. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group was founded in 1898 and is headquartered in Chicago, Illinois.

QUEST DIAGNOSTICS INC (NYSE:DGX) - Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. It offers patients and physicians the access to diagnostic testing services through its network of laboratories and patient service centers; and interpretive consultation services. The company provides commercial clinical testing services, including routine clinical testing for blood chemistries, complete blood cell counts, urinalyses, pregnancy and other prenatal tests, routine microbiology testing, prescription drug monitoring, alcohol and other substance-abuse tests, and allergy tests; gene-based and esoteric testing; and anatomic pathology services, as well as risk assessment services for the life insurance industry. It also develops and integrates clinical connectivity and data management solutions for healthcare organizations, physicians, and clinicians through its Care360 suite of products; and offers Centergy Data Exchange and the ChartMaxx electronic document management system to hospitals. In addition, the company provides central laboratory testing services in connection with clinical research trials on new drugs, vaccines, and medical devices; and clinical testing to employers for the detection of employee use of drugs-of-abuse. Further, it develops and manufactures products that enable healthcare professionals to make healthcare diagnoses, including HerpeSelect ELISA tests that detect patient antibodies to certain types of herpes simplex virus, and sells to academic medical centers, hospitals, and commercial laboratories; White Blood Cell Analyzer for performing whole-blood test on finger-stick samples; and InSure fecal immunochemical test for screening for colorectal cancer. The company was founded in 1967 and is headquartered in Madison, New Jersey.

WALGREEN CO (NYSE:WAG) - Walgreen Co., together with its subsidiaries, engages in the operation of a chain of drugstores in the United States. The companys drugstores sell prescription and non-prescription drugs, and general merchandise. Its general merchandise comprises household products, convenience foods, and seasonal items, as well as personal care, beauty care, candy, and photofinishing products. The company offers its products and services through drugstores, as well as through mail, telephone, and the Internet. As of December 17, 2010, it operated 7,650 drugstores in 50 states, the District of Columbia, and Puerto Rico. The company also owns 37 strip shopping malls. Walgreen Co. was founded in 1901 and is based in Deerfield, Illinois.

BROADRIDGE FINANCIAL SOLUTIO (NYSE:BR) - Broadridge Financial Solutions, Inc. provides technology-based solutions to the financial services industry in the United States, Canada, and the United Kingdom. The company operates through three segments: Investor Communication Solutions, Securities Processing Solutions, and Clearing and Outsourcing Solutions. The Investor Communication Solutions segment involves in the processing and distribution of proxy materials to investors in equity securities and mutual funds, and facilitation of related vote processing; and distribution of regulatory reports and corporate action/reorganization event information, as well as provides tax reporting solutions. This segment also offers financial information distribution and transaction reporting services to financial institutions and securities issuers; shareholder forum and virtual shareholder meeting solutions; and data aggregation and data management solutions. The Securities Processing Solutions segment offers computerized real-time transaction processing services, which automate the securities transaction cycle. Its products and services include desktop productivity tools, portfolio management, order capture and execution, trade confirmation, settlement, and accounting. The Clearing and Outsourcing Solutions segment provides securities transaction execution, clearing, and settlement services, including matching, recording, and processing transaction instructions, as well as exchanging payment between counterparties; and operations outsourcing services. This segment also offers financing for client inventory through margin lending. The company offers its services to retail and institutional brokerage firms, global banks, mutual funds, annuity companies, institutional investors, specialty trading firms, and clearing firms, as well as to corporate issuers. Broadridge Financial Solutions Inc. has a strategic alliance with Calculated Design, Inc. The company is headquartered in Lake Success, New York.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net